Personalized Medicine in the Genomics Era: Highlights from an international symposium on childhood heart disease

Future Cardiology

Volumn 8, Issue 2, 2012, Pages 157-160

  Farra, Natalie ^a,b   Manickaraj, Ashok Kumar ^b   Ellis, James ^a,b   Mital, Seema ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

biobanking; congenital heart disease; genomics; pediatrics; personalized medicine; stem cell

Indexed keywords

BIOINFORMATICS; CONFERENCE PAPER; CONGENITAL HEART DISEASE; FUNDING; GENETIC ANALYSIS; GENOMICS; GOVERNMENT; HEALTH CARE; HEART DISEASE; HUMAN; MEDICAL ETHICS; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; POPULATION RESEARCH; PRIORITY JOURNAL; STEM CELL GENE THERAPY;

CONGRESSES AS TOPIC; GENOMICS; HEART DEFECTS, CONGENITAL; HUMANS; INDIVIDUALIZED MEDICINE; INTERNATIONAL COOPERATION; PHARMACOGENETICS; STEM CELL TRANSPLANTATION;

EID: 84858667843     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.12.3     Document Type: Conference Paper

References (20)

1. Altshuler D, Durbin RM, Abecasis GR et al. 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467(7319), 1061-1073 (2010
2. Greenway SC, Pereira AC, Lin JC et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat. Genet. 41(8), 931-935 (2009
3. Girard SL, Gauthier J, Noreau A et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat. Genet. 43(9), 860-863 (2011
4. O'Roak BJ, Deriziotis P, Lee C et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat. Genet. 43(6), 585-589 (2011
5. Berkel S, Tang W, Trevino M et al. Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology. Hum. Mol. Genet. 21(2), 344-357 (2011
6. Fiume M, Williams V, Brook A, Brudno M. SaVant: genome browser for high-throughput sequencing data. Bioinformatics 26(16), 1938-1944 (2010
7. Singh D, Orellana CF, Hu Y et al. FDM: a graph-based statistical method to detect differential transcription using RNA-seq data. Bioinformatics 27(19), 2633-2640 (2011
8. Lesko LJ, Zineh I. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA. Pharmacogenomics 11(4), 507-512 (2010
9. Ito S, Carleton BC. Predictive genotype. CMAJ 182(8), 804 (2010
10. Gijsen V, Mital S, Van Schaik RH et al. Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients. J. Heart Lung Transplant. 30(12), 1352-1359 (2011
11. Mital S. Personalizing medicine for the child with heart disease: a path forward. J. Cardiovasc. Pharmacol. 58(1), 1-3 (2011
12. Patrick AR, Avorn J, Choudhry NK. Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation.Circ. Cardiovasc. Qual. Outcomes 2(5), 429-436 (2009
13. Sun N, Longaker MT, Wu JC. Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle 9(5), 880-885 (2010
14. Cheung AY, Horvath LM, Grafodatskaya D et al. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet. 20(11), 2103-2115 (2011
15. Dubois NC, Craft AM, Sharma P et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat. Biotechnol. 29(11), 1011-1018 (2011
16. Hussein SM, Batada NN, Vuoristo S et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471(7336), 58-62 (2011
17. Cassar PA, Stanford WL. Integrating post-transcriptional regulation into the embryonic stem cell gene regulatory network. J. Cell Physiol. 227(2), 439-449 (2012
18. Kattman SJ, Witty AD, Gagliardi M et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8(2), 228-240 (2011
19. Braam SR, Tertoolen L, Van de Stolpe A, Meyer T, Passier R, Mummery C. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 4(2), 107-116 (2010
20. Nunes SS, Song H, Chiang CK, Radisic M. Stem cell-based cardiac tissue engineering. J. Cardiovasc. Transl. Res. 4(5), 592-602 (2011)